• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低氧上调的 circELP3 促进膀胱癌进展和顺铂耐药性。

Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.

机构信息

The Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

The Department of Urology, Yan'an Hospital Affiliated with Kunming Medical University, Kunming, China.

出版信息

Int J Biol Sci. 2019 Jan 1;15(2):441-452. doi: 10.7150/ijbs.26826. eCollection 2019.

DOI:10.7150/ijbs.26826
PMID:30745833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6367558/
Abstract

Hypoxia plays a critical role in cancer biology. It induces genomic instability, which in turn helps cancer cells respond adaptively to meet the needs of carcinogenesis, cancer progression and relapse. Circular RNA has not been reported among the variety of downstream factors in this adaptive response. Although a few studies have demonstrated the important role of circular RNAs in driving human bladder cancer progression, their carcinogenic roles are still under investigated. Here, we identified a hypoxia-elevated circular RNA, circELP3, that contributes to bladder cancer progression and cisplatin resistance. Decreasing the level of circELP3 via siRNA clearly reduced the proliferation and cisplatin resistance of bladder cancer cells and promoted apoptosis. Interfering with circELP3 suppressed tumor xenograft growth in nude mice . In addition, lower circELP3-expressing bladder cancer cells displayed poorer self-renewal capacity, as demonstrated by lower levels of sphere formation and stem cell marker expression. Furthermore, in human bladder cancer patients, strong correlations between a high circELP3 level and advanced tumor grade and lymph node metastasis were observed. In summary, we provide the first direct evidence that circular RNA participates in the adaptive response to hypoxia and may play a role in the progression and drug resistance of bladder cancer.

摘要

缺氧在癌症生物学中起着关键作用。它诱导基因组不稳定性,进而帮助癌细胞适应环境,以满足致癌、癌症进展和复发的需求。在这种适应性反应的多种下游因素中,尚未报道环状 RNA 的存在。尽管有几项研究表明环状 RNA 在推动人类膀胱癌进展方面发挥了重要作用,但它们的致癌作用仍在研究中。在这里,我们鉴定了一个受缺氧上调的环状 RNA,circELP3,它有助于膀胱癌的进展和顺铂耐药性。通过 siRNA 降低 circELP3 的水平可明显降低膀胱癌细胞的增殖和顺铂耐药性,并促进细胞凋亡。干扰 circELP3 可抑制裸鼠中的肿瘤异种移植生长。此外,circELP3 表达水平较低的膀胱癌细胞表现出较差的自我更新能力,球体形成和干细胞标志物表达水平较低。此外,在人类膀胱癌患者中,观察到高水平的 circELP3 与高级别肿瘤和淋巴结转移之间存在强烈相关性。综上所述,我们提供了第一个直接证据,证明环状 RNA 参与了对缺氧的适应性反应,并且可能在膀胱癌的进展和耐药性中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/847c4878b9bd/ijbsv15p0441g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/9529baadbf3f/ijbsv15p0441g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/5191bffbc15a/ijbsv15p0441g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/7a97211d5801/ijbsv15p0441g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/07ecc88b8449/ijbsv15p0441g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/6fb4c1e97221/ijbsv15p0441g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/80618789eca0/ijbsv15p0441g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/847c4878b9bd/ijbsv15p0441g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/9529baadbf3f/ijbsv15p0441g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/5191bffbc15a/ijbsv15p0441g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/7a97211d5801/ijbsv15p0441g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/07ecc88b8449/ijbsv15p0441g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/6fb4c1e97221/ijbsv15p0441g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/80618789eca0/ijbsv15p0441g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/536c/6367558/847c4878b9bd/ijbsv15p0441g007.jpg

相似文献

1
Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.低氧上调的 circELP3 促进膀胱癌进展和顺铂耐药性。
Int J Biol Sci. 2019 Jan 1;15(2):441-452. doi: 10.7150/ijbs.26826. eCollection 2019.
2
Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.环状 RNA Cdr1as 通过抑制 miR-1270 上调 APAF1 表达使膀胱癌对顺铂敏感。
Mol Oncol. 2019 Jul;13(7):1559-1576. doi: 10.1002/1878-0261.12523. Epub 2019 Jun 9.
3
Interaction with WTAP Promotes Assembly and Activity of the mA Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer.WTAP 相互作用促进 mA 甲基转移酶复合物的组装和活性,并促进膀胱癌的顺铂耐药性。
Cancer Res. 2021 Dec 15;81(24):6142-6156. doi: 10.1158/0008-5472.CAN-21-1518. Epub 2021 Oct 26.
4
Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.组蛋白去甲基化酶 KDM7A 调节雄激素受体活性,其化学抑制剂 TC-E 5002 克服膀胱癌细胞对顺铂的耐药性。
Int J Mol Sci. 2020 Aug 6;21(16):5658. doi: 10.3390/ijms21165658.
5
CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.环状 RNA UGGt2 通过非同源末端连接途径促进膀胱癌的进展和顺铂耐药性。
Cell Signal. 2024 Jul;119:111164. doi: 10.1016/j.cellsig.2024.111164. Epub 2024 Apr 5.
6
Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer.化疗药物诱导的Oct4表达导致膀胱癌的耐药性和肿瘤复发。
Oncotarget. 2017 May 9;8(19):30844-30858. doi: 10.18632/oncotarget.9602.
7
Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer.癌症干细胞样细胞促进膀胱癌对顺铂耐药和进展。
Cancer Lett. 2012 Sep 1;322(1):70-7. doi: 10.1016/j.canlet.2012.02.010. Epub 2012 Feb 15.
8
NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.NF-κB 信号通路在顺铂诱导的膀胱癌化疗耐药和肿瘤进展中发挥着不可替代的作用。
Int J Oncol. 2016 Jan;48(1):225-34. doi: 10.3892/ijo.2015.3256. Epub 2015 Nov 20.
9
Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.敲低Bmi1可通过在G1期阻断细胞周期并诱导凋亡来抑制膀胱癌细胞在体外和体内的生长。
J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):730-735. doi: 10.1007/s11596-015-1498-y. Epub 2015 Oct 22.
10
Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.环状RNA circUBXN7通过吸附miR-1247-3p以增强B4GALT3在膀胱癌中的表达,从而抑制细胞生长和侵袭。
Aging (Albany NY). 2018 Oct 12;10(10):2606-2623. doi: 10.18632/aging.101573.

引用本文的文献

1
Deciphering the role of circular RNAs in cancer progression under hypoxic conditions.解读环状RNA在缺氧条件下癌症进展中的作用。
Med Oncol. 2025 May 2;42(6):191. doi: 10.1007/s12032-025-02727-z.
2
Circular RNAs: driving forces behind chemoresistance and immune evasion in bladder cancer.环状RNA:膀胱癌化疗耐药和免疫逃逸背后的驱动力
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 25. doi: 10.1007/s00210-025-04032-y.
3
Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment.缺氧肿瘤微环境中的非编码RNA图谱

本文引用的文献

1
Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.miR-223 双链的两条互补链(miR-223-5p 和 miR-223-3p)抑制癌细胞侵袭性:靶基因参与膀胱癌的发病机制。
J Hum Genet. 2018 May;63(5):657-668. doi: 10.1038/s10038-018-0437-8. Epub 2018 Mar 14.
2
Cancer stem cells as key drivers of tumour progression.肿瘤干细胞作为肿瘤进展的关键驱动因素。
J Biomed Sci. 2018 Mar 6;25(1):20. doi: 10.1186/s12929-018-0426-4.
3
Atezolizumab and bladder cancer: facing a complex disease.
Genes (Basel). 2025 Jan 24;16(2):140. doi: 10.3390/genes16020140.
4
Development of hepatocellular carcinoma organoid model recapitulating HIF-1A metabolic signature.开发重现 HIF-1A 代谢特征的肝癌类器官模型。
Clin Exp Med. 2024 Nov 21;25(1):9. doi: 10.1007/s10238-024-01521-x.
5
Tumor hypoxia in immune infiltration and prognosis of bladder cancer.肿瘤缺氧在膀胱癌免疫浸润及预后中的作用
Transl Cancer Res. 2024 Jul 31;13(7):3273-3284. doi: 10.21037/tcr-23-2375. Epub 2024 Jul 26.
6
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells.缺氧癌细胞化疗耐药背后的缺氧诱导因子依赖性和非依赖性机制
Cancers (Basel). 2024 Apr 29;16(9):1729. doi: 10.3390/cancers16091729.
7
Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner.芹菜素7-葡萄糖苷以p16依赖性方式抑制缺氧诱导的宫颈癌细胞恶性表型。
Open Life Sci. 2024 Mar 20;19(1):20220819. doi: 10.1515/biol-2022-0819. eCollection 2024.
8
Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.非编码RNA转录本,通过调控广泛的细胞过程和信号机制,成为膀胱癌顺铂化疗耐药的惊人调节因子。
Noncoding RNA Res. 2024 Jan 22;9(2):560-582. doi: 10.1016/j.ncrna.2024.01.009. eCollection 2024 Jun.
9
N-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges.N6-甲基腺苷修饰的 circ_104797 通过作为 RNA 海绵维持膀胱癌对顺铂的耐药性。
Cell Mol Biol Lett. 2024 Feb 23;29(1):28. doi: 10.1186/s11658-024-00543-3.
10
Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p.环状RNA_0000235通过吸附miR-330-5p靶向单羧酸转运蛋白4,促进膀胱癌的糖酵解及进展。
Cell Death Discov. 2023 Aug 2;9(1):283. doi: 10.1038/s41420-023-01582-z.
阿替利珠单抗与膀胱癌:面对一种复杂的疾病
Lancet. 2018 Jan 27;391(10118):305-306. doi: 10.1016/S0140-6736(18)30095-3. Epub 2018 Jan 31.
4
Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.环状 RNA circ-ITCH 通过海绵吸附 miR-17/miR-224 并调节 p21、PTEN 表达抑制膀胱癌进展。
Mol Cancer. 2018 Jan 31;17(1):19. doi: 10.1186/s12943-018-0771-7.
5
Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.环状 RNA cSMARCA5 抑制肝癌的生长和转移。
J Hepatol. 2018 Jun;68(6):1214-1227. doi: 10.1016/j.jhep.2018.01.012. Epub 2018 Jan 31.
6
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.化疗耐药性肌肉浸润性膀胱癌的突变模式。
Nat Commun. 2017 Dec 19;8(1):2193. doi: 10.1038/s41467-017-02320-7.
7
Bladder cancer: Multi-omic profiling refines the molecular view.膀胱癌:多组学分析完善分子视角。
Nat Rev Clin Oncol. 2018 Apr;15(4):203-204. doi: 10.1038/nrclinonc.2017.195. Epub 2017 Dec 19.
8
Advances in Hypoxia-Inducible Factor Biology.缺氧诱导因子生物学的进展。
Cell Metab. 2018 Feb 6;27(2):281-298. doi: 10.1016/j.cmet.2017.10.005. Epub 2017 Nov 9.
9
MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.MicroRNA-154 作为膀胱癌的一个预后因素,通过靶向 RSF1 和 RUNX2 抑制细胞恶性程度。
Oncol Rep. 2017 Nov;38(5):2727-2734. doi: 10.3892/or.2017.5992. Epub 2017 Sep 25.
10
Hypoxia-Targeting, Tumor Microenvironment Responsive Nanocluster Bomb for Radical-Enhanced Radiotherapy.缺氧靶向、肿瘤微环境响应性纳米簇炸弹用于激进增强放射治疗。
ACS Nano. 2017 Oct 24;11(10):10159-10174. doi: 10.1021/acsnano.7b04737. Epub 2017 Oct 11.